Kardigan, Inc. — Company profile
Healthcare · Biotechnology · United States
Last price 14.31 USD (Oct 29, 2026, 4:00 PM EDT) · Market cap 1.34B
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Company profile
Kardigan, Inc. operates as a biopharmaceutical company focused on developing medicines for cardiovascular diseases. The company develops and provides a portfolio of medicines that target the underlying pathophysiology of cardiovascular diseases, including primary and secondary cardiomyopathies leading to heart failure. It utilizes a proprietary research and development platform that integrates AI-based tools, real-world clinical data, and cardiac-specific analytics to optimize clinical study design, patient screening, and efficacy tracking. The company incorporates Prolaio’s cardiovascular data collection and analytics platform, which includes FDA-cleared algorithms and high-density patient data, to support drug development and clinical intelligence. The company engages in strategic in-licensing and acquisitions to expand its pipeline of targeted treatments. Kardigan serves biopharmaceutical companies, cardiovascular researchers, and healthcare providers in the cardiology sector. The company was formerly known as EnCarda, Inc. and changed its name to Kardigan, Inc. in December 2024. The company was founded in 2023 and is based in Princeton, New Jersey.
Details
| Name | Kardigan, Inc. |
| Sector | Healthcare |
| Industry | Biotechnology |
| Employees | 241 |
| Founded | 2023 |
| Ipo Date | 2026-06-18 |
| Ceo | Tassos Anastasios Gianakakos |
| Country | United States |
| Exchange | NASDAQ |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| Ipo Price | 16.00 |
| Isin | US4859251013 |
| Cusip | 485925101 |
| Cik | 2123613 |
| Sic | 2834 |
| Stock Type | Common Stock |
Key executives
| Name | Title |
|---|---|
| Tassos Anastasios E. Gianakakos M.Sc., MBA | Co-Founder, President, Chief Executive Officer and Chairman |
| Dr. Jay Edelberg M.D., Ph.D. | Co-founder and Chief Medical Officer |
| Brianne Puglisi | Chief Financial Officer |
| Dr. Bob McDowell Ph.D. | Co-founder and Scientific Advisor |
| Dr. Leslie A. Leinwand Ph.D. | Co-Founder |
| Dr. Elizabeth McNally M.D., Ph.D. | Co-Founder |
| Donald Mackenzie Ph.D. | Chief Technical Operations Officer |
| Clayton Robertson | Vice President of Investor Relations |
| John B. Moriarty Jr., ESQ., J.D. | Chief Legal Officer and Corporate Secretary |
| Emily Faucette | Chief Communications Officer |
Contact
| Address | 506 Carnegie Center Drive, Suite 201, Princeton, New Jersey 08540, United States |
| Phone | (415) 573-3220 |
| Website | https://www.kardigan.bio |